| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.64▲ | 5.64▲ | 5.64▲ | 5.98▼ | 5.12▲ |
| MA10 | 5.60▲ | 5.57▲ | 5.56▲ | 5.74▼ | 5.03▲ |
| MA20 | 5.51▲ | 5.69▼ | 5.78▼ | 4.93▲ | 5.38▲ |
| MA50 | 5.88▼ | 5.98▼ | 5.77▼ | 5.01▲ | 10.83▼ |
| MA100 | 5.96▼ | 5.65▼ | 5.05▲ | 5.08▲ | 24.91▼ |
| MA200 | 5.62▲ | 4.90▲ | 4.75▲ | 5.27▲ | 30.63▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.043▲ | 0.020▲ | -0.015▼ | 0.136▲ | 0.590▲ |
| RSI | 49.117▼ | 46.143▼ | 47.119▼ | 57.019▲ | 45.634▼ |
| STOCH | 72.775 | 75.810 | 65.242 | 68.349 | 36.878 |
| WILL %R | -25.000▲ | -22.222▲ | -63.158 | -41.620 | -49.412 |
| CCI | 64.711 | 66.523 | 18.551 | 39.834 | 52.300 |
|
Thursday, May 01, 2025 04:30 AM
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the ...
|
|
Wednesday, April 30, 2025 01:50 AM
I can think of two great targets off the top of my head. Let's start with Altimmune (NASDAQ: ALT). The company has what it calls "a pipeline in a product" with experimental GLP-1/glucagon dual ...
|
|
Tuesday, April 29, 2025 06:48 PM
The filing from Nasdaq comes just three weeks after 21Shares submitted an S-1 application to introduce a spot-based Dogecoin ETF. This ETF would be structured as a commodity-based trust, designed to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 5.66 | 5.73 | 5.58 | 5.65 | 45,229 |
| 30/04/25 | 5.95 | 5.96 | 5.31 | 5.56 | 114,000 |
| 29/04/25 | 6.60 | 6.60 | 5.92 | 5.95 | 152,214 |
| 28/04/25 | 6.34 | 7.14 | 5.91 | 6.43 | 222,000 |
| 25/04/25 | 5.67 | 6.50 | 5.65 | 6.32 | 222,279 |
| 24/04/25 | 5.52 | 5.79 | 5.33 | 5.79 | 77,700 |
| 23/04/25 | 5.69 | 5.82 | 5.17 | 5.51 | 117,808 |
| 22/04/25 | 5.60 | 5.615 | 5.22 | 5.47 | 106,013 |
| 21/04/25 | 5.14 | 5.83 | 5.14 | 5.56 | 248,871 |
| 17/04/25 | 4.30 | 5.3152 | 4.22 | 5.15 | 503,738 |
|
|
||||
|
|
||||
|
|